Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.1124351 
Contract referenceInst. Nac. de Cancer-2026-00395 
Contract description:ADQUISICION DE BEVACIZUMAB Y TRASTUZUMAB 
Goods 
Contract Start:
13 days ago (24/07/2026 00:00:00(UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
07/11/2026 00:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateAccepted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-03-ComparacionDePrecios 
Inst. Nac. de Cancer-CCC-CP-2026-0007 
ADQUISICION DE BEVACIZUMAB Y TRASTUZUMAB 
ADQUISICON DE BEVACIZUMAB Y TRASTUZUMAB 
ALMACEN GENERAL Y SUMINISTROS 
ADQUISICION DE BEVACIZUMAB Y TRASTUZUMAB_EXT 
GoodsDominicana 
5,225,856 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
13 days ago (24/07/2026 00:00:00(UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
04/11/2026 00:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
nstituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares Av. Correa y Cidrón, Esq. Rafael A. Sánchez Ravelo, Zona Universitaria DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline30 days 

Contract Comments

Contract Comments


 
 
 1 
DO1.PCCNTR.2310548 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
5,225,856.000.000.000.006,093,666.785,225,856.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
51111713 - Alemtuzumab
2.3.4.1.01Bevacizumab 100MG INY Combinado270UD8,221.597,2351,953,450.000.000.000.002,219,829.301,953,450.00
    
1
51111713 - Alemtuzumab
2.3.4.1.01Bevacizumab 400MG INY Combinado210UD12,732.5611,6092,437,890.000.000.000.002,673,837.602,437,890.00
    
1
51111717 - Trastuzumab
2.3.4.1.01Trastuzumab 440MG/5ML Vial36UD33,333.3323,181834,516.000.000.000.001,199,999.88834,516.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download
Download
Download
Download

Budget Settings

Budget Settings

Operation
Own resources
5,225,856.00 DOP
5,225,856.00 DOP
AccountValueAnnual Availability
2.3.4.1.015,225,856.00  DOP
5,225,856.00  DOP
View
Payment Calendar
IDDescriptionValueMonthYear
0  ADQUISICION DE BEVACIZUMAB Y TRASTUZUMAB5,225,856.00  DOPDiciembre2026
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
2026EG1781795404167gtzzX15,225,856.00  DOPLink